Holderness Investments Company’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.11M | Sell |
75,100
-852
| -1% | -$22.7K | 0.42% | 64 |
|
|
2025
Q4 | $1.89M | Sell |
75,952
-8,766
| -10% | -$221K | 0.38% | 63 |
|
|
2025
Q3 | $2.16M | Sell |
84,718
-9,309
| -10% | -$230K | 0.44% | 58 |
|
|
2025
Q2 | $2.28M | Sell |
94,027
-32,058
| -25% | -$748K | 0.49% | 53 |
|
|
2025
Q1 | $3.19M | Buy |
126,085
+26,915
| +27% | +$704K | 0.74% | 35 |
|
|
2024
Q4 | $2.63M | Buy |
99,170
+193
| +0.2% | +$5.24K | 0.58% | 41 |
|
|
2024
Q3 | $2.86M | Buy |
98,977
+74
| +0.1% | +$2.16K | 0.63% | 41 |
|
|
2024
Q2 | $2.77M | Sell |
98,903
-1,677
| -2% | -$46.2K | 0.65% | 36 |
|
|
2024
Q1 | $2.79M | Sell |
100,580
-21,166
| -17% | -$587K | 0.68% | 39 |
|
|
2023
Q4 | $3.51M | Buy |
121,746
+25,176
| +26% | +$761K | 0.96% | 29 |
|
|
2023
Q3 | $3.2M | Sell |
96,570
-2,195
| -2% | -$77.6K | 1.25% | 18 |
|
|
2023
Q2 | $3.62M | Sell |
98,765
-8,395
| -8% | -$327K | 1.34% | 16 |
|
|
2023
Q1 | $4.37M | Sell |
107,160
-1,431
| -1% | -$61.8K | 1.75% | 9 |
|
|
2022
Q4 | $5.56M | Sell |
108,591
-723
| -0.7% | -$34.7K | 2.4% | 5 |
|
|
2022
Q3 | $4.78M | Sell |
109,314
-2,731
| -2% | -$133K | 2.17% | 7 |
|
|
2022
Q2 | $5.88M | Sell |
112,045
-4,327
| -4% | -$221K | 2.45% | 5 |
|
|
2022
Q1 | $6.03M | Sell |
116,372
-845
| -0.7% | -$43.8K | 2.01% | 6 |
|
|
2021
Q4 | $6.92M | Buy |
117,217
+2,423
| +2% | +$120K | 2.04% | 7 |
|
|
2021
Q3 | $4.94M | Sell |
114,794
-1,109
| -1% | -$49.1K | 1.63% | 10 |
|
|
2021
Q2 | $4.54M | Buy |
115,903
+26
| +0% | +$1.01K | 1.5% | 11 |
|
|
2021
Q1 | $4.2M | Buy |
115,877
+742
| +0.6% | +$26.3K | 1.51% | 12 |
|
|
2020
Q4 | $4.24M | Buy |
115,135
+5,965
| +5% | +$219K | 1.64% | 8 |
|
|
2020
Q3 | $3.8M | Buy |
109,170
+32,445
| +42% | +$1.14M | 1.57% | 13 |
|
|
2020
Q2 | $2.38M | Buy |
76,725
+8,701
| +13% | +$296K | 1.06% | 24 |
|
|
2020
Q1 | $2.11M | Sell |
68,024
-835
| -1% | -$28.5K | 1.19% | 23 |
|
|
2019
Q4 | $2.56M | Sell |
68,859
-242
| -0.4% | -$8.62K | 1.1% | 24 |
|
|
2019
Q3 | $2.36M | Sell |
69,101
-11,600
| -14% | -$422K | 1.1% | 24 |
|
|
2019
Q2 | $3.32M | Buy |
80,701
+3,452
| +4% | +$137K | 1.5% | 17 |
|
|
2019
Q1 | $3.11M | Sell |
77,249
-631
| -0.8% | -$25.3K | 1.49% | 16 |
|
|
2018
Q4 | $3.23M | Buy |
77,880
+1,457
| +2% | +$60.5K | 1.76% | 13 |
|
|
2018
Q3 | $3.19M | Buy |
76,423
+2,040
| +3% | +$78.5K | 1.44% | 16 |
|
|
2018
Q2 | $2.56M | Sell |
74,383
-254
| -0.3% | -$8.68K | 1.24% | 18 |
|
|
2018
Q1 | $2.51M | Buy |
74,637
+232
| +0.3% | +$7.98K | 1.24% | 18 |
|
|
2017
Q4 | $2.56M | Buy |
74,405
+209
| +0.3% | +$7.13K | 1.26% | 19 |
|
|
2017
Q3 | $2.51M | Sell |
74,196
-514
| -0.7% | -$16.5K | 1.31% | 18 |
|
|
2017
Q2 | $2.38M | Sell |
74,710
-16,421
| -18% | -$518K | 1.26% | 17 |
|
|
2017
Q1 | $2.96M | Buy |
91,131
+20,895
| +30% | +$659K | 1.5% | 15 |
|
|
2016
Q4 | $2.16M | Buy |
70,236
+22,547
| +47% | +$688K | 1.92% | 14 |
|
|
2016
Q3 | $1.53M | Sell |
47,689
-158
| -0.3% | -$5.28K | 1.53% | 19 |
|
|
2016
Q2 | $1.6M | Sell |
47,847
-21,772
| -31% | -$695K | 1.61% | 19 |
|
|
2016
Q1 | $1.96M | Buy |
69,619
+248
| +0.4% | +$7.08K | 1.87% | 15 |
|
|
2015
Q4 | $2.13M | Buy |
69,371
+580
| +0.8% | +$18.2K | 2.1% | 9 |
|
|
2015
Q3 | $2.05M | Buy |
68,791
+1,157
| +2% | +$37.1K | 2.15% | 7 |
|
|
2015
Q2 | $2.15M | Sell |
67,634
-322
| -0.5% | -$10.5K | 2.2% | 7 |
|
|
2015
Q1 | $2.24M | Buy |
67,956
+19,961
| +42% | +$635K | 2.28% | 4 |
|
|
2014
Q4 | $1.42M | Buy |
+47,995
| New | +$1.38M | 1.45% | 22 |
|
Other funds holding PFE
VCM
VPM
Holderness Investments Company's PFE Position: Q1 2026 in Review
Holderness Investments Company reduced its Pfizer (PFE) stake by 1.1% in Q1 2026, selling an estimated $22.7K and leaving 75,100 shares worth $2.11M. The position accounts for 0.42% of the portfolio, ranked #64.
Holderness Investments Company first reported a position in PFE in Q4 2014 and has held it in 46 quarters since. The position peaked at $6.92M in Q4 2021. 2,939 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- Holderness Investments Company held 75,100 shares of Pfizer worth $2.11M as of Q1 2026.
- Holderness Investments Company sold 852 Pfizer shares in Q1 2026, an estimated $22.7K.
- Pfizer made up 0.42% of Holderness Investments Company's portfolio in Q1 2026, its #64 holding.
- Holderness Investments Company first reported a position in Pfizer in Q4 2014 and has held it in 46 quarters since.
- Holderness Investments Company's Pfizer position peaked at $6.92M in Q4 2021.
- 2,939 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on Holderness Investments Company's 13F filing for Q1 2026, filed 12 May 2026.